American Century Companies Inc Pro Phase Labs, Inc. Transaction History

American Century Companies Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$4.23 - $7.53 $8,307 - $14,788	1,964 Added 2.63%	76,531 $334,000
Q2 2023 Aug 14, 2023	SELL	$7.15 - $9.78 $40,032 - $54,758	-5,599 Reduced 6.98%	74,567 $541,000
Q1 2023 May 11, 2023	BUY	$6.62 - $9.57 $87,172 - $126,017	13,168 Added 19.65%	80,166 $610,000
Q4 2022 Feb 13, 2023	BUY	$8.78 - $12.47 $158,935 - $225,731	18,102 Added 37.02%	66,998 $645,000
Q3 2022 Nov 14, 2022	BUY	$8.96 - $14.7 $438,108 - $718,771	48,896 New	48,896 $552,000

1.71M

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $10.1M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.